Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
* Rituxan - Generic: Rituximab | * Rituxan - Generic: Rituximab | ||
* Zevalin - Generic: Ibritumomab | * Zevalin - Generic: Ibritumomab | ||
| - | =====[[ | + | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== |
* Herceptin - Generic: Trastuzumab | * Herceptin - Generic: Trastuzumab | ||
* [[Iressa]] - Generic: Gefitinib | * [[Iressa]] - Generic: Gefitinib | ||
* [[Tarceva]] - Generic: Erlotinib | * [[Tarceva]] - Generic: Erlotinib | ||
* [[Tykerb]] - Generic: Lapatinib | * [[Tykerb]] - Generic: Lapatinib | ||
| - | =====[[ | + | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== |
| + | * [[Avastin]] - Generic: Bevacizumab | ||
| + | =====[[Vascular Endothelial Growth Factor Receptor]] Inhibitor===== | ||
* Sutent - Generic: Sunitinib | * Sutent - Generic: Sunitinib | ||
* Nexavar - Generic: Sorafenib | * Nexavar - Generic: Sorafenib | ||
| - | =====[[VEGF]] Inhibitor===== | ||
| - | * [[Avastin]] - Generic: Bevacizumab | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Revision as of 12:50, 6 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Vascular Endothelial Growth Factor Inhibitor
Vascular Endothelial Growth Factor Receptor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
